- Question from Tigs: I was HER2+ (diagnosed in July of 06). I was wondering if there is anything out there on further treatment. I had a year of Herceptin but was hoping for some additional treatment.
- Answers - Kathy D. Miller, M.D. We know that treatment with a year of Herceptin (chemical name: trastuzumab) dramatically reduces the risk of recurrence so you should be feeling very good about your prognosis. But the fear of recurrence is always an issue. There is a study ongoing currently looking at adding treatment with an oral inhibitor of the HER2 factor after women have completed a year of Herceptin in the adjuvant setting. That study is still actively enrolling patients, so we have not seen any results from that study yet.
The Ask-the-Expert Online Conference called Updates From the 2009 San Antonio Breast Cancer Symposium featured Kathy Miller, M.D. and Kristin Brill, M.D., F.A.C.S. answering your questions about the latest updates on breast cancer risk, screening techniques, treatment options, and more.
Editor's Note: This conference took place in December 2009.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.